最新更新 :
22/08/2024
Infostab
药品清单
简要表
搜索兼容性
Y 站点兼容性表
引用文献
研究小組
valistab
海报
鏈接
贊助商
作者
使用指南
时讯
Vancomycin hydrochloride
化学式
商品名
商品名仅供参考, 药品所用的辅料可能依国家或厂商不同有所不同。
Amplobac
巴西
Anco L IV
土耳其
Celovan
印度, 委内瑞拉, 巴西, 秘鲁
Dhacocin
马来西亚
Edicin
土耳其, 斯洛文尼亚, 波兰, 罗马尼亚
Estafimac
墨西哥
Estavam
墨西哥
Imvaco
智利
Kovan
智利
Rivervan
阿根廷
Tancofeto
哥伦比亚, 马来西亚
Vacsol
墨西哥
Valcidem
墨西哥
Vamysin
卢森堡, 比利时
Vanaurus
厄瓜多尔, 哥伦比亚
Vanbiotic
厄瓜多尔, 哥伦比亚
Vancam
墨西哥
Vancobact
埃及
Vancobiotic
秘鲁
Vancocare
印度
Vancocin
加拿大, 匈牙利, 卢森堡, 印度, 奥地利, 沙特阿拉伯, 波兰, 澳大利亚, 爱尔兰, 瑞典, 瑞士, 美国, 英国, 荷兰, 阿联酋
Vancocina
巴西, 意大利
Vancofar
秘鲁
Vancogen
印度
Vancoled
印度, 阿联酋
Vancolon
埃及, 沙特阿拉伯, 阿联酋
Vancomate
印度
Vancomax
伊朗, 厄瓜多尔, 秘鲁, 阿根廷
Vancomicina
厄瓜多尔, 哥伦比亚, 墨西哥, 意大利, 智利, 突尼斯, 罗马尼亚, 葡萄牙, 西班牙, 阿根廷
Vancomix
埃及
Vancomycin
丹麦, 冰岛, 加拿大, 匈牙利, 埃及, 奥地利, 希腊, 德国, 挪威, 新西蘭, 沙特阿拉伯, 澳大利亚, 爱尔兰, 瑞典, 美国, 芬兰, 英国, 阿联酋
Vancomycine
卢森堡, 埃及, 摩洛哥, 比利时, 法国, 瑞士, 荷兰
Vanconat
印度
Vanconor
秘鲁
Vancorin
印度, 土耳其, 马来西亚
Vancosan
希腊, 德国
Vancoser
印度
Vancotek
土耳其
Vancotex
意大利
Vancox
墨西哥
Vankomisin
土耳其
Vanlid
印度, 委内瑞拉, 马来西亚
Varedet
厄瓜多尔, 哥伦比亚, 秘鲁, 阿根廷
Yestafhal
墨西哥
Zengac
意大利
引用文献 : Vancomycin hydrochloride
种类
出版物
3
文献
Trissel LA, Martinez JF.
Compatibility of amifostine with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1995 ; 52: 2208-2212.
59
文献
Trissel LA, Gilbert DL, Martinez JF, Kim MC.
Compatibility of remifentanil hydrochloride with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1997 ; 54: 2192-2196.
63
文献
Marquardt Ed, Lam SSY.
Visual compatibility of fentanyl citrate with selected drugs during simulated Y-site injection.
Am J Hosp Pharm 1994 ; 51: 811-812.
73
文献
Lor E, Takagi J.
Visual compatibility of foscarnet with other injectable drugs.
Am J Hosp Pharm 1990 ; 47: 157-159.
81
文献
Trissel LA, Martinez JF.
Compatibility of piperacillin sodium plus tazobactam with selected drugs during simulated Y-site injection.
Am J Hosp Pharm 1994 ; 51: 672-678.
84
文献
Trissel LA, Martinez JF.
Visual, turbidimetric, and particle-content assessment of compatibility of vinorelbine tartrate with selected drugs during simulated Y-site injection.
Am J Hosp Pharm 1994 ; 51: 495-499.
85
文献
Trissel LA, Bready BB.
Turbidimetric assessment of the compatibility of taxol with selected other drugs during simulated Y-site injection.
Am J Hosp Pharm 1992 ; 49: 1716-1719.
91
文献
Lober CA, Dollard PA.
Visual compatibility of gallium nitrate with selected drugs during Y-site injection.
Am J Hosp Pharm 1993 ; 50: 1208-1210.
93
文献
Hutchings SR, Rusho WJ, Tyler LS.
Compatibility of cefmetazole sodium with commonly used drugs during Y-site delivery.
Am J Health-Syst Pharm 1996 ; 53: 2185-2188.
94
文献
Chandler SW, Folstad J, Trissel LA.
Aztreonam-vancomycin incompatibility.
Am J Hosp Pharm 1990 ; 47: 1970.
95
文献
Pritts D, Hancock D.
Incompatibility of ceftriaxone with vancomycin.
Am J Hosp Pharm 1991 ; 48: 77.
99
文献
Trissel LA, Martinez JF.
Compatibility of aztreonam with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1995 ; 52: 1086-1090.
129
文献
Smythe M, Malouf E.
Visual compatibility of insulin with secondary intravenous drugs in admixtures.
Am J Hosp Pharm 1991 ; 48: 125-126.
132
文献
Najari Z, Rusho WJ.
Compatibility of commonly used bone marrow transplant drugs during Y-site delivery.
Am J Health-Syst Pharm 1997 ; 54: 181-184.
150
文献
Aujoulat P, Coze C, Braguer D, Raybaud C.
Physicochemical compatibility of methotrexate with co-administered drugs during cancer chemotherapy regimens.
J Pharm Clin 1993 ; 12: 31-35.
169
文献
Trissel LA, Martinez JF.
Physical compatibility of melphalan with selected drugs during simulated Y-site administration.
Am J Hosp Pharm 1993 ; 50: 2359-2363.
176
文献
Mantong ML, Marquardt ED.
Visual compatibility of midazolam hydrochloride with selected drugs during simulated Y-site injection.
Am J Health-Syst Pharm 1995 ; 52: 2567-2568.
182
文献
Trissel LA, Gilbert DL, Martinez JF.
Compatibility of granisetron hydrochloride with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1997 ; 54: 56-60.
186
文献
Swart EL, Mooren RAG, Van Loenen AC.
Compatibility of midazolam hydrochloride and lorazepam with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1995 ; 52: 2020-2022.
198
文献
Gayed AA, Kheshary PR, Hinkle RL.
Visual compatibility of diltiazem injection with various diluents and medications during simulated Y-site injection.
Am J Health-Syst Pharm 1995 ; 52: 516-520.
244
文献
Trissel LA, Martinez JF.
Compatibility of filgrastim with selected drugs during simulated Y-site administration.
Am J Hosp Pharm 1994 ; 51: 1907-1913.
249
文献
Trissel LA, Martinez JF.
Compatibility of thiotepa (lyophilized) with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1996 ; 53: 1041-1045.
251
文献
Trissel LA, Gilbert DL, Martinez JF.
Compatibility of doxorubicin hydrochloride liposome injection with selected other drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1997 ; 54: 2708-2713.
253
文献
Trissel LA, Chandler SW, Folstad JT.
Visual compatibility of amsacrine with selected drugs during simulated Y-site injection.
Am J Hosp Pharm 1990 ; 47: 2525-2528.
260
文献
Szof C, Walker PC.
Incompatibility of cefotaxime sodium and vancomycin sulfate during Y-site administration.
Am J Hosp Pharm 1993 ; 50: 2054, 2057.
264
文献
Leboucher G, Charpiat B.
Incompatibilité physico-chimique entre l’oméprazole et la vancomycine.
Pharm Hosp Fr 1997 ; 121: 124.
266
文献
Patel PR.
Compatibility of meropenem with commonly used injectable drugs.
Am J Health-Syst Pharm 1996 ; 53: 2853-2855.
280
文献
Allen LV, Stiles ML, Prince SJ, Sylvestri MF.
Stability of cefpirome sulfate in the presence of commonly used intensive care drugs during simulated Y-site injection.
Am J Health-Syst Pharm 1995 ; 52: 2427-2433.
284
文献
Trissel LA, Xu QA, Martinez JF.
Compatibility and stability of aztreonam and vancomycin hydrochloride.
Am J Health-Syst Pharm 1995 ; 52: 2560-2564.
299
文献
Trissel LA, Martinez JF, Gilbert DL.
Compatibility of cisatracurium besylate with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1997 ; 54: 1735-1741.
300
文献
Trissel LA, Gilbert DL, Martinez JF.
Compatibility of propofol injectable emulsion with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1997 ; 54: 1287-1292.
301
文献
Trissel LA, Gilbert DL, Martinez JF, Baker MB, Walter WV, Mirtallo JM.
Compatibility of parenteral nutrient solutions with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1997 ; 54: 1295-1300.
307
文献
Trissel LA, Martinez JF.
Compatibility of allopurinol sodium with selected drugs during simulated Y-site administration.
Am J Hosp Pharm 1994 ; 51: 1792-1799.
315
文献
Bahal SM, Lee TJ, McGinnes M, Dobler GL.
Visual compatibility of warfarin sodium injection with selected medications and solutions.
Am J Health-Syst Pharm 1997 ; 54: 2599-2600.
316
文献
Veltri M, Lee CKK.
Compatibility of neonatal parenteral nutrient solutions with selected intravenous drugs.
Am J Health-Syst Pharm 1996 ; 53: 2611-2613.
317
文献
Kershaw BP, Monnier HL, Mason JH.
Visual compatibility of premixed theophylline or heparin with selected drugs for IV administration.
Am J Hosp Pharm 1993 ; 50: 1360-1362.
334
文献
Trissel LA, Tramonte SM, Grilley BJ.
Visual compatibility of ondansetron hydrochloride with selected drugs during simulated Y-site injection.
Am J Hosp Pharm 1991 ; 48: 988-992.
335
文献
Trissel LA, Bready BB, Kwan JW, Santiago NM.
Visual compatibility of sargramostim with selected antineoplasic agents, anti-infectives, or other drugs during simulated Y-site injection.
Am J Hosp Pharm 1992 ; 49: 402-406.
336
文献
Forman JK, Lachs JR, Souney PF.
Visual compatibility of acyclovir sodium with commonly used intravenous drugs during simulated Y-site injection.
Am J Hosp Pharm 1987 ; 44: 1408-1409.
337
文献
Bashaw ED, Amantea MA, Minor JR, Galleli JF.
Visual compatibility of zidovudine with other drugs during simulated Y-site administration.
Am J Hosp Pharm 1988 ; 45: 2532-2533.
384
文献
Colucci RD, Cobuzzi LE, Halpern NA.
Visual compatibility of esmolol hydrochloride and various injectable drugs during simulated Y-site injection.
Am J Hosp Pharm 1988 ; 45: 630-632.
385
文献
Benedict MK, Roche VF, Banakar UV, Hilleman DE.
Visual compatibility of amiodarone hydrochloride with various antimicrobial agents during simulated Y-site injection.
Am J Hosp Pharm 1988 ; 45: 1117-1118.
386
文献
Colucci RD, Cobuzzi LE, Halpern NA.
Visual compatibility of labetalol hydrochloride injection with various injectable drugs during simulated Y-site injection.
Am J Hosp Pharm 1988 ; 45: 1357-1358.
402
文献
Savitsky ME.
Visual compatibility of neuromuscular blocking agents with various injectable drugs during simulated Y-site injection.
Am J Hosp Pharm 1990 ; 47: 820-821.
405
文献
Nieves-Cordero AL, Luciw HM, Souney PF.
Compatibility of narcotic analgesic solutions with various antibiotics during simulated Y-site injection.
Am J Hosp Pharm 1985 ; 42: 1108-1109.
428
文献
Nahata MC, Miller MA, Durrell DE.
Stability of vancomycin hydrochloride in various concentrations of dextrose injection.
Am J Hosp Pharm 1987 ; 44: 802-804.
430
文献
Das Gupta V, Stewart KR, Nohria S.
Stability of vancomycin hydrochloride in 5% dextrose and 0.9% sodium chloride injections.
Am J Hosp Pharm 1986 ; 43: 1729-1731.
479
文献
Min DI, Brown T, HWang GC.
Visual compatibility of tacrolimus with commonly used drugs during simulated Y-site injection.
Am J Hosp Pharm 1992 ; 49: 2964-2966.
491
文献
Turowski RC, Durthaler JM.
Visual compatibility of idarubicin hydrochloride with selected drugs during simulated Y-site injection.
Am J Hosp Pharm 1991 ; 48: 2181-2184.
492
文献
Trissel LA, Parks NPT, Santiago NM.
Visual compatibility of fludarabine phosphate with antineoplastic drugs, anti-infectives, and other selected drugs during simulated Y-site injection.
Am J Hosp Pharm 1991 ; 48: 2186-2189.
496
文献
Lor E, Sheybani T, Takagi J.
Visual compatibility of fluconazole with commonly used injectable drugs during simulated Y-site administration.
Am J Hosp Pharm 1991 ; 48: 744-746.
552
文献
Martinez JF, Trissel LA, Gilbert DL.
Compatibility of warfarin sodium with selected drugs and large-volume parenteral solutions.
Int J Pharm Compound 1997 ; 1: 356-358.
604
实验室
Stabilité des médicaments dans l'Intermate® SV50, 100, 200
Baxter 1998
654
文献
Allen LV.
Stability of vancomycin hydrochloride in Medication Cassette* reservoirs.
Int J Pharm Compound 1997 ; 1: 123-124.
660
文献
Michaels MR, Stauffer GL, Haas DP.
Propofol compatibility with other intravenous drug products - Two new methods of evaluating IV emulsion compatibility.
Ann Pharmacotherapy 1996 ; 30: 228-232.
694
文献
Walker SE, Birkhans B.
Stability of intravenous vancomycin.
Can J Hosp Pharm 1988 ; 41: 233-238, 242.
702
文献
Biellmann-Berlaud V, Willemin JC.
Stability of vancomycin in polyolefine or PVC bags and glass vials.
J Pharm Clin 1998 ; 17: 145-148.
889
文献
Janknegt R, Stratermans T, Cilissen J, Lohman JJHM, Hooymans PM.
Ofloxacin intravenous. Compatibility with other antibacterial agents.
Pharm Weekbl [Sci] 1991 ; 13: 207-209.
891
文献
Matsuura G.
Visual compatibility of sargramostim (GM-CSF) during simulated Y-site administration with selected agents.
Hosp Pharm 1992 ; 27: 200, 202, 209.
895
文献
Yao JDC, Arkin CF, Karchmer AW.
Vancomycin stability in heparin and total parenteral nutrition solutions: novel approach to therapy of central venous catheter-related infections.
JPEN 1992 ; 16: 268-274.
905
文献
Trissel LA, Martinez JF.
Screening teniposide for Y-site physical incompatibilities.
Hosp Pharm 1994 ; 29: 1010-1017.
913
文献
Wood MJ, Lund R, Beavan M.
Stability of vancomycin in plastic syringes measured by high-performance liquid chromatography.
J Clin Pharm Ther 1995 ; 20: 319-325.
921
文献
Trissel LA, Gilbert DL, Martinez JF.
Incompatibility and compatibility of amphotericin B cholesteryl sulfate complex with selected other drugs during simulated Y-site administration.
Hosp Pharm 1998 ; 33: 284-292.
931
文献
Galanti LM, Hecq JD, Vanbeckbergen D, Jamart J.
Long-term stability of vancomycin hydrochloride in intravenous infusions.
J Clin Pharm Ther 1997 ; 22: 353-356.
939
文献
Gilbar PJ, Groves CF.
Visual compatibility of total parenteral nutrition solution (Synthamin 17 Premix*) with selected drugs during simulated Y-site injection.
Aust J Hosp Pharm 1994 ; 24: 167-170.
966
文献
Martins AM, McDougal A, Hamilton D, Igwemezie L, McErlane K.
In vitro assessment of vancomycin HCl compatibility after coinfusion with a specialized amino acid formulation.
JPEN 1991 ; 15: 536-539.
999
文献
Watson D.
Piggyback compatibility of antibiotics with pediatric parenteral nutrition solution.
JPEN 1985 ; 9: 220-224.
1047
文献
Souney PF, Colucci RD, Mariani G, Campbell D.
Compatibility of magnesium sulfate solutions with various antibiotics during simulated Y-site injection.
Am J Hosp Pharm 1984 ; 41: 323-324.
1057
文献
Cutie MR.
Compatibility of verapamil hydrochloride injection with commonly used additives.
Am J Hosp Pharm 1983 ; 40: 1205-1207.
1072
文献
Saltsmann CL, Tom CM, Mitchell A, Fan JH, Gailey RA.
Compatibility of levofloxacin with 34 medications during simulated Y-site administration.
Am J Health-Syst Pharm 1999 ; 56: 1458-1459.
1135
文献
Baltz JK, Kennedy P, Minor JR, Gallelli J.
Visual compatibility of foscarnet with other injectable drugs during simulated Y-site administration.
Am J Hosp Pharm 1990 ; 47: 2075-2077.
1167
文献
Grennberg RN, Saeed AM, Kennedy DJ, McMillian R.
Instability of vancomycin in infusaid drug pump model 100.
Antimicrob Agents Chemother 1987 ; 31: 610-611.
1201
文献
Yuhas EM, Lofton FT, Rosenberg HA, Mayron D, Baldinus JG.
Cimetidine hydrochloride compatibility III: Room temperature stability in drug admixtures.
Am J Hosp Pharm 1981 ; 38: 1919-1922.
1315
文献
Halpern NA, Colucci RD, Alicea M, Greenstein R.
Visual compatibility of enalaprilat with commonly used critical care medications during simulated Y-site injection.
Int J Pharm Clin Pharmacol Ther Tox 1989 ; 27: 294-297.
1399
文献
Cairns CJ, Robertson J.
Incompatibility of ceftazidime and vancomycin.
Pharm J 1987 ; 238: 577.
1410
文献
Trissel LA, Martinez JF, Simmons M.
Compatibility of etoposide phosphate with selected drugs during simulated Y-site injection.
J Am Pharm Assoc 1999 ; 39: 141-145.
1414
文献
Mayer JLR, Pascale VJ, Clyne LP, Malkus H, Santos FS, van Hoff J.
Stability of low-dose vancomycin hydrochloride in heparin sodium 100 UI / ml.
J Pharm Technol 1999 ; 15: 13-17.
1415
文献
Trissel L.A, Gilbert D.L, Martinez J.F, Baker M.B, Walter W.V, Mirtallo J.M.
Compatibility of medications with 3-in-1 parenteral nutrition admixtures.
JPEN 1999 ; 23: 67-74.
1416
文献
Stamatakis MK, Leader G, Tracy TS.
Stability of high-dose vancomycin and ceftazidime in peritoneal dialysis solutions.
Am J Health-Syst Pharm 1999 ; 56: 246-248.
1423
文献
Trissel LA, Martinez JF, Gilbert DL.
Compatibility of gemcitabine hyrochloride with 107 selected drugs during simulated Y-site injection.
J Am Pharm Assoc 1999 ; 39: 514-518.
1490
文献
Halpern NA, Colucci RD, Alicea M, Greenstein R.
The compatibility of nicardipine hydrochloride injection with various ICU medications during simulated Y-site injection.
Int J Pharm Clin Pharmacol Ther Tox 1989 ; 27: 250-254.
1508
文献
Voirol P, Berger-Gryllaki M, Pannatier A, Eggimann P, Sadeghipour F.
Visual compatibility of insulin aspart with intravenous drugs frequently used in ICU.
EJHP 2015 ;22:123-124.
1611
文献
Chalmers JR, Bobek MB, Militello MA.
Visual compatibility of amiodarone hydrochloride injection with various intravenous drugs.
Am J Health-Syst Pharm 2001 ; 58: 504-506.
1614
文献
Trissel LA, Xu QA, Zhang Y, Saenz CA, Ingram DS.
Stability of ciprofloxacin and vancomycin hydrochloride in autodose infusion system bags.
Hosp Pharm 2001 ; 36: 1170-1173.
1625
文献
Trissel LA, Saenz C, Williams YW, Ingram D.
Incompatibilities of lansoprazole injection with other drugs during simulated Y-site coadministration.
Int J Pharm Compound 2001 ; 5: 314-321.
1649
文献
Gilbar P, McAllan Z.
Ticarcillin-potassium clavulanate and vancomycin incompatibility.
Aust J Hosp Pharm 1997 ; 27: 470.
1671
文献
Khalfi F, Dine T, Gressier B, Luyckx M, Brunet C, Ballester L, Goudaliez F, Cazin M, Cazin JC.
Compatibility and stability of vancomycin hydrochloride with PVC infusion material in various conditions using stability-indicating high-performance liquid chromatographic assay.
Int J Pharm 1996 ; 139: 243-247.
1674
文献
Trissel LA, Gilbert DL, Martinez JF.
Concentration dependency of vancomycin hydrochloride compatibility with beta-lactam antibiotics during simulated Y-site administration.
Hosp Pharm 1998 ; 33: 1515-1522.
1712
文献
Trissel LA, Saenz CA.
Compatibility screening of Precedex during simulated Y-site administration with other drugs.
Int J Pharm Compound 2002 ; 6: 230-233.
1713
文献
Trissel LA, Saenz CA.
Compatibility screening of bivalirudin during simulated Y-site administration with other drugs.
Int J Pharm Compound 2002 ; 6: 311-315.
1721
文献
Trissel LA, Williams KY, Baker MB.
Compatibility screening of Hextend during simulated Y-site administration with other drugs.
Int J Pharm Compound 2001 ; 5: 69-72.
1748
文献
Wang DP, Wang MT, Wong CY, Lee DKT.
Compatibility of vancomycin hydrochloride and famotidine in 5% dextrose injection.
Int J Pharm Compound 1997 ; 1: 354-355.
1754
文献
Trissel LA, Gilbert DL, Wolkin AC.
Compatibility of docetaxel with selected drugs during simulated Y-site administration.
Int J Pharm Compound 1999 ; 3: 241-244.
1759
文献
Servais H, Tulkens PM.
Stability and compatibility of ceftazidime administered by continuous infusion to intensive care patients.
Antimicrob Agents Chemother 2001 ; 45: 2643-2647.
1802
文献
Bell MS, Nolt DH.
Visual compatibility of doxapram hydrochloride with drugs commonly administered via a Y-site in the intensive care nursery.
Am J Health-Syst Pharm 2003 ; 60: 193-194.
1803
文献
Trissel, LA, Saenz CA, Ogundele OB, Ingram D, Baker MB.
Compatibility of fenoldopam mesylate with other drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2003 ; 60: 80-85.
1868
文献
Husson E, Crauste-Manciet S, Hadj-Salah E, ,Segier JC, Broissard D.
Stabilité galénique de mélanges commercialisés de nutrition parentérale en présence de médicaments: médicaments dans le mélange.
Nutr Clin Metab 2003 ; 17: 8-14.
1871
文献
Sautou-Miranda V, Libert F, Grand-Boyer A, Gellis C, Chopineau J.
Impact of deep freezing on the stability of 25 mg/ml vancomycin ophtalmic solutions.
Int J Pharm 2002 ; 234: 205-212.
1877
文献
Lifshitz T, Lapid-Gortzak R, Finkelman Y, Klemperer I.
Vancomycin and ceftazidime incompatibility upon vitreal injection.
Br Ophtalmol 2000 ; 84: 117.
1925
文献
Trissel LA , Williams KY, Gilbert DL.
Compatibility screening of linezolid injection during simulated Y-site administration with other drugs and infusion solutions.
J Am Pharm Assoc 2000 ; 40: 515-519.
1953
文献
Trissel LA, Saenz CA, Ogundele AB, Ingram DS.
Physical compatibility of pemetrexed disodium with other drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2004 ; 61: 2289-2293.
1959
文献
Mac Lellan C, Papadopoulos A.
Precipitate formation after subconjonctival administration of ceftazidime and vancomycin.
Hosp Pharm 2005 ; 40, 2: 154-155.
1982
文献
Trissel LA, Ogundele AB.
Compatibility of anidulafungin with other drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2005 ; 62: 834-837.
2034
文献
Rodenbach MP, Hecq JD, Vanbeckbergen D, Jamart J, Galanti L.
Effect of freezing, long-term storage and microwave thawing on the stability of vancomycin hydrochloride in 5% dextrose infusions.
EJHP Science 2005 ; 11, 5: 111-113.
2037
文献
Robinson JL, Tawfik G, Saxinger L, Stang L, Etches W, Lee B.
Stability of heparin and physical compatibility of heparin/antibiotic solutions ...
J Antimicrob Chemother 2005 ; 56: 951-953.
2087
文献
Ferreira E, Forest JM, Hildgen P.
Compatibility of dimenhydrinate injectable by Y administration.
Pharmactuel 2004 ; 37: 17-20.
2090
文献
Pere H, Chasse V, Forest JM, Hildgen P.
Compatibility of injectable pantoprazole in Y-site administration.
Pharmactuel 2004 ; 37: 193-196.
2109
文献
Pelletier E, Forest JM, Hildgen P.
Compatibilité de la kétamine injectable lors de l’administration en dérivé avec d’autres médicaments usuels.
Pharmactuel 2006 ; 39: 71-75.
2139
文献
Serrurier C, Chenot ED, Vigneron J, May I, Demor? B.
Assessment of injectable drug’s administration in two intensive care units and determination of potential physico-chemical incompatibilities.
EJHP Science 2006 ; 12,5: 96-99.
2141
文献
Barinian N, Chanteux H, Viaene E, Servais H, Tulkens PM.
Stability and compatibility study of cefepime in comparaison with ceftazidime for potential administration by continuous infusion under conditions pertinent to ambulatory treatment of cystic fibrosis patients and to administration in intensive care units.
J Antimicrob Chemother 2003 ; 51: 651-658.
2147
文献
Nornoo AO, Elwell RJ.
Stability of vancomycin in icodextrin peritoneal dialysis solution.
Ann Pharmacotherapy 2006 ; 40, 11: 1950-1954.
2173
文献
Grioffiths W, Favet J, Ing H, Sadeghipour F, Bonnabry P.
Chemical stability and microbiological potency of intravenous vancomycin hydrochloride syringes for use in the neonatal intensive care.
EJHP Science 2006 ; 12, 6: 135-139.
2192
文献
Cochran BG, Sowinski KM, Fausel C, Overholser BR.
Physical compatibility and chemical stability of mycophenolate mofetil during simulated Y-site administration with commonly coadministered drugs.
Am J Health-Syst Pharm 2007 ; 64, 13: 1410-1414.
2228
文献
Kupiec T, Ben M, Trusley C, Trissel LA.
Compatibility and stability of palonosetron hydrochloride with gentamicin, metronidazole, or vancomycin during simulated Y-site administration.
Int J Pharm Compound 2008 ; 12,2: 170-173.
2231
文献
de Jongh R, Hens R, Basma V, mouton JW, Tulkens PM, Carryn S.
Continuous versus intermittent infusion of temocillin, a directed spectrum penicillin for intensive care patients with nosocomial pneumonia: stability, compatibility, population pharmacokinetic studies and breakpoint selection.
J Antimicrob Chemother 2008 ; 61, 2: 382-388.
2233
文献
Condie C.K, Tyler L.S, Barker B, Canann D.M.
Visual compatibility of caspofungin acetate with commonly used drugs during simulated Y-site delivery
Am J Health-Syst Pharm 2008 ; 65, 5: 454-457.
2247
文献
Chan P, Heatherly K, Kupiec T.C, Trissel L.A.
Compatibility of caspofungin acetate injection with other drugs during simulated Y-site coadministration.
Int J Pharm Compound 2008 ; 12, 3: 276-278.
2262
文献
Brammer MK, Chan P, Heatherly K, Trusley C, Kupiec TC, Trissel LA, Psathas PA, Gilmor T, Schaufelberger D.
Compatibility of doripenem with other drugs during simulated Y-site administratioN
Am J Health-Syst Pharm 2008 ; 65: 1261-1265.
2335
文献
Canann D, Tyler L.S, Barker B, Condie C.
Visual compatibility of i.v. medications routinely used in bone marrow transplant recipients
Am J Health-Syst Pharm 2009 ; 66, 8: 727-729
2370
文献
Mawhinney WM, Adair CG, Gorman SP, McClurg B.
Stability of vancomycin hydrochloride in peritoneal dialysis solution
Am J Hosp Pharm 1992 ; 49: 137 - 139.
2375
文献
Strong DK, Ho W, Nairn JG.
Visual compatibility of vancomycin and heparin in peritoneal dialysis solutions
Am J Hosp Pharm 1989 ; 46: 1832 - 1833.
2475
文献
Wade J, Cooper M, Ragan R.
Simulated Y-Site Compatibility of Vancomycin and Piperacillin-Tazobactam
Hosp Pharm 2015 ; 50: 376-379.
2530
文献
Bartoll A, Bellés Medall M, Peñarrocha J, Escrig L, Clemente R, Azuara J.
Physicochemical and Microbiological Stability of Vancomycin 10-mg/mL Intravitreal Syringes.
Int J Pharm Compound 2022 ;26,4:330-335
3012
文献
Sullivan T, Forrest J.M, Leclair G.
Compatibility of Cloxacillin Sodium with Selected Intravenous Drugs During Simulated Y-Site Administration
Hosp Pharm 2015 ; 50, 3: 214-220.
3101
文献
Wazny LD, Blake PG.
Incompatibility of Vancomycin and Ceftazidime for Intraperitoneal Use.
Perit Dial Int 2002 ; 22: 93-94.
3120
海报
Maillot-Pyszczek V, Bourdeaux D, Sautou V, Chopineau J.
Etude de stabilité de solutions intravitréennes de vancomycine à 10 mg/ml.
Congrès HOPIPHARM 2010
3122
文献
Dotson B, Lynn S, Savakis K, Churchwell MD.
Physical compatibility of 4% sodium citrate with selected antimicrobial agents.
Am J Health-Syst Pharm 2010 ; 67: 1195-1198.
3125
文献
Baker D S, Waldrop Bruce, Arnold John.
Compatibility and Stability of Cefotaxine, Vancomycin, and Ciprofloxacin in Antibiotic Lock Solutions Containing Heparin.
Int J Pharm Compound 2010 ; 14, 4: 346-349.
3201
文献
Dice JE.
Physical compatibility of alprostadil with commonly used IV solutions and medications in the neonatal intensive care unit.
J Pediatr Pharmacol Ther 2006 ; 11:233?6.
3216
文献
Legris ME, Valiquette ME, Lavoie A, Forest JM, Leclair G.
Compatibilité physique par évaluation visuelle du salbutamol injectable lors de son administration en Y.
Pharmactuel 2011 ; 44, 1 : 14-18
3327
文献
LaPlante K.L, Woodmansee S, Mermel L.A.
Compatibility and stability of telavancin and vancomycin in heparin or sodium citrate lock solutions.
Am J Health-Syst Pharm 2012 ; 69:1405-1409
3365
文献
Nichols K.R, DeMarco M.W, Vertin M.D, Knoderer C.A.
Y-Site Compatibility of Vancomycin and Piperacillin/Tazobactam at Commonly Utilized Pediatric Concentrations.
Hosp Pharm 2013 ; 1: 44-47
3385
文献
Raverdi V, Ampe E, Hecq JD, Tulkens PM.
Stability and compatibility of vancomycin for administration by continuous infusion.
J Antimicrob Chemother 2013 ; 68: 1179-1182.
3408
文献
Tollec S, Touzin K, Pelletier E, Forest J.M.
Evaluation visuelle de la compatibilité physique de la naloxone avec d’autres médicaments intraveineux usuels.
Pharmactuel 2013 ; 46, 1 : 16-21.
3421
文献
Leung E, Venkatesan N, Ly S.C, Scheetz M.H.
Physical compatibility of vancomycin and piperacillin sodium–tazobactam at concentrations typically used during prolonged infusions.
Am J Health-Syst Pharm 2013 ;70:1163-1166.
3428
文献
Nichols K.R, DeMarco M.W, Vertin M.D, Knoderer C.A.
Y-site compatibility of vancomycin and piperacillin/tazobactam at commonly utilized pediatric concentrations.
Hosp Pharm 2013 ; 48, 1: 44-47.
3485
文献
Huey-Ping Ng, Kwong-Fah Koh, Lai-San Tham.
Vancomycin causes dangerous precipitation when infused with gelatin fluid.
Anaesthesia 2000 ; 55, 10: 1039-1040.
3523
实验室
Ceftriaxone (Rocephin®) - Summary of Product Characteristics.
Roche 2018
3539
实验室
Bivalirudin (Angiox®) - Summary of Product Characteristics.
The Medecines Company 2013
3540
实验室
Heparin sodium - Summary of Product Characteristics.
Wockhardt 2010
3542
文献
Berti A.D, Hutson P.R, Schulz L.T, Webb A.P, Rose W.E.
Compatibility of cefepime and vancomycin during simulated Y-site administration of prolonged infusion
Am J Health-Syst Pharm 2015 ; 72:390-395
3543
实验室
Ceftazidime – Summary of Product Characteristics
Wockhardt 2013
3548
实验室
Cefepime (Maxipime®) - Summary of Product caracteristics.
Bristol Myers Squibb 2007
3557
文献
Chan A, Tawfik G, Cheng W.
Physical Incompatibility between Parenteral Cloxacillin and Vancomycin.
Can J Hosp Pharm 2013 ; 66, 5: 310-312
3564
实验室
Rocuronium B Braun - Résumé des caractéristiques du produit.
B Braun 2012
3571
文献
Anderson C, Boehme S, Ouellette J, Stidham C, MacKay M.
Physical and Chemical Compatibility of Injectable Acetaminophen During Simulated Y-Site Administration.
Hosp Pharm 2014 ; 49, 1: 42-47.
3588
实验室
Vancomycine (Vancocin®) - Résumé des caractéristiques du produit
Sandoz 2011
3662
实验室
Foscavir (Foscarnet®) - Summary of Product Characteristics
Clinigen 2014
3668
实验室
Dexamethasone - Summary of Product Characteristics
Hospira 2015
3728
文献
Correard F, Savry A, Gauthier-Villano L, Pisano P, Pourroy B.
Visual compatibility of defibrotide with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2014 ; 71: 1288-1291.
3767
文献
Legris M.E, Lavoie A, Forrest J.M, Hildgen P.
Compatibilité par évaluation visuelle du thiopental injectable lors de son administration en Y avec des médicaments usuels.
Pharmactuel 2014 ; 47, 3 : 167-172.
3791
海报
Sadou Yaye H, Burtet E, Hamel C, Aljhni R, Gard C, Tilleul P.
Étude de la compatibilité physico-chimique du phloroglucinol injectable durant les mélanges au sein des tubulures en Y.
Apifh Congress, Paris November 2014 2014
3813
文献
Teibel H.M, Knoderer C.A, Nichols K.R.
Compatibility of Vancomycin and Oxacillin During Simulated Y-Site Delivery.
Hosp Pharm 2015 ; 50, 8: 710-713.
3824
文献
Boudi S, Roy H, Forest JM, Leclair G.
Compatibilité physique de l'association amoxicilline-acide clavulanique en injection avec plusieurs autres médicaments lors d'une administration en Y.
Pharmactuel 2023 2023;56,3:91-98
3827
海报
Ghazi I.M, Hamada Y, Nicolau D.P.
Compatibility of tedizolid phosphate with selected intravenous drugs via simulated Y-site conditions.
ASHP Midyear 2015
3828
海报
Thabit A.K, Hamada Y, Nicolau D.P.
Ceftozolane/tazobactam physical compatibility during simulated Y-site administration.
ASHP Midyear 2015
3829
海报
So W, Kim L, Thabit A.K, Nicolau D.P, Kuti J.L.
Compatibility of isavunazonium sulfate during simulated Y-site administration.
ASHP Midyear 2015
3841
文献
Nicholas O?Donnell J, Venkatesan N, Manek M, Rhodes N.J, Scheetz M.H.
Visual and absorbance analyses of admixtures containing vancomycin and piperacillin–tazobactam at commonly used concentrations.
Am J Health-Syst Pharm 2016 ; 73:241-246
3883
实验室
Ceftazidime - Résumé des caractéristiques du produit
Arrow 2016
3888
文献
Ranganathan D, Naicker S,. Wallis S.C, Lipman J, . Ratanjee S.K, Roberts J.A
Stability of Antibiotics for Intraperitoneal Administration in Extraneal 7.5% Icodextrin Peritoneal Dialysis Bags (STAB Study).
Perit Dial Int 2016 ; 36:421-426.
3948
文献
Bouchoud L, Fonzo-Christe C, Klingm?ller M, Bonnabry P .
Compatibility of Intravenous Medications With Parenteral Nutrition - In Vitro Evaluation.
JPEN 2012 ;30. 416?424.
3951
文献
Battistella M, Walker S, law S, Lok C.
Antibiotic lock: In vitro stability of vancomycin and four percent sodium citrate stored in dialysis catheters at 37°C
Hemodial Int 2009 ; 13, 3: 322-328.
3956
文献
Bastani B; Amin K; Herr A.
Prolonged Stability of Stored Vancomycin, Gentamicin, and Heparin for Use in the Antibiotic-Lock Technique.
ASAIO Journal 2005 ; 51,6:761-763.
3958
文献
Henrickson K.J; . Powell K.R; . Schwartz C.L.
A Dilute Solution of Vancomycin and Heparin Retains Antibacterial and Anticoagulant Activities .
J Infect Dis 1988 ; 157, 3: 600-601.
3960
文献
Kufel W.D, Miller C.D, Johnson P.R, Reid K., Zahra J.J, Seabury R.W.
Y-site Incompatibility Between Premix Concentrations of Vancomycin and Piperacillin-Tazobactam: Do Current Compatibility Testing Methodologies Tell the Whole Story?
Hosp Pharm 2017 ;52,2:132-137.
3964
文献
Audet M.A, Forest E, Friciu M, Forest J.M, Leclair G.
Compatibilité du citrate de caféine injectable avec plusieurs autres médicaments.
Pharmactuel 2017 ; 50,1 : 27-33.
3976
文献
Du Repaire T, Vigne P, Guedon A, Gauthier-Villano L, Bertault Peres P, Pourroy B.
Visual compatibility of blinatumomab with selected co-administrated drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2017 ; 74,16 : 1217-1218
3984
文献
Meyer K, Santarossa M, Danziger L.H, Wenzler E.
Compatibility of Ceftazidime-Avibactam, Ceftolozane-Tazobactam and Piperacillin-Tazobactam with Vancomycin in Dextrose 5% in Water.
Hosp Pharm 2017 ,52;3 : 221-228
3985
海报
Manai M., Soussi M.A., Lazreg O., Drira C., Ben Tekaya S. et Razgallah Khrouf M.
Compatibilité physique entre médicaments injectables et nutrition parentérale pédiatrique : Evaluation in-vitro.
Hopipharm Congress 2017 - Nancy 2017
3997
文献
Katip W.
Visual compatibility of colistin injection with other antibiotics during simulated Y-site administration.
Am J Health-Syst Pharm 2017 ; 74:14 : 1099-1102
4007
海报
Masse M, Genay S, Carta N, Delannoy-Rousseli?re C, Moreau F, Barthelemy C, Faure K, Decaudin B, Odou P.
Etude de la stabilité de la vancomycine à 40 mg/ml au cours d'une perfusion de 24 heures.
Hopipharm Congress 2017-Nancy 2017
4027
文献
Wei Y, WonJoon Yang J, Boddu S, Jung R, Churchwell M.
Compatibility, Stability, and Efficacy of Vancomycin Combined With Gentamicin or Ethanol in Sodium Citrate as a Catheter Lock Solution.
Hosp Pharm 2017 ;52,10:685-690
4055
文献
Monogue M, Almarzoky Abuhussain S, Kuti J, Nicolau D.
Physical compatibility of fosfomycin for injection with select i.v. drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2018 , 75, 1:36-44
4089
文献
Godet M, Simar J, Closset M, Hecq J.D, Braibant M, Soumoy L, Gillet P, Jamart J, Bihin B, Galanti L.
Stability of Concentrated Solution of Vancomycin Hydrochloride in Syringes for Intensive Care Units.
Pharmaceutical Technology in Hospital Pharmacy 2018 ;3,1:23-30
4128
海报
Masse M, Genay S, Carta N, Moreau F, Delannoy-Rousselière C, Barthélémy C, Décaudin B, Faure K, Odou P.
Stabilité de la vancomycine à des doses méningées dans les seringues au cours d'une perfusion de 24 heures.
GRITA Symposium Perfusion 2017, Lille, France. 2017
4145
文献
Asempa T.E, Avery L.M, Kidd J.M, Kuti J.L, Nicolau D.P.
Physical compatibility of plazomicin with select i.v. drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2018 ;75,14:1048-1056
4254
文献
D'Huart E, Vigneron J, Demoré B.
Physical Compatibility of Intravenous Drugs Commonly Used in Intensive Care Units: An Observational Study and Physical Compatibility Laboratory Tests on Anti-Infective Drugs
Pharmaceutical Technology in Hospital Pharmacy 2019 ;4,1:29-40
4319
文献
Lessard J-J, Caron E, Schérer H, Forest J-M, Leclair G.
Compatibility of Y-site Injection of Meropenem Trihydrate With 101 Other Injectable Drugs.
Hosp Pharm 2020 ; 55, 5: 332-337.
4348
文献
D'Huart E, Vigneron J, Charmillon A, Clarot I, Demoré B.
Physicochemical Stability of Vancomycin at High Concentrations in Polypropylene Syringes.
Can J Hosp Pharm 2019 ;72(5):360-8
4354
海报
Sicard G, Donnette M, Martin N, Gensollen S, Pourroy B, Fanciullino R.
Compatibilité visuelle du Vyxeos lors d'administration en Y avec une sélection de médicaments injectables.
GERPAC Congress 2019 2019
4373
文献
Masse M, Genay S, Martin Mena A, Carta N, Lannoy D, Barthélémy C, Décaudin B, Odou P.
Evaluation of the stability of vancomycin solutions at concentrations used in clinical services.
EJHP 2020 ; 27(e1):e87-e92.
4380
实验室
Posaconazole (Noxafil®) - Summary of Product Characteristics
Merck Sharp & Dohme Limited 2019
4419
文献
Holt R.J, Siegert S.W.K, Krishna A.
Physical Compatibility of Ibuprofen Lysine Injection with Selected Drugs During Simulated Y-site Injection.
J Pediatr Pharmacol Ther 2008 ; 13, 3: 155-161.
4434
文献
Avery L.M, Chen, I.H, Reyes, S, Nicolau, D.P, Kuti J.L.
Assessment of the Physical Compatibility of Eravacycline and Common Parenteral Drugs During Simulated Y-site Administration.
Clin Ther 2019 ; 41, 10: 2162-2170.
4440
文献
Omotani S, Aoe M, Esaki S, Nagai K, Hatsuda Y, Mukai J, Teramachi H, Myotoku M.
Compatibility of Intravenous Fat Emulsion with Antibiotics for Secondary Piggyback Infusion.
Ann Nutr Metab 2018 ; 73: 227-233.
4470
文献
Claeysoone K, Basma V, Hens R, Van Bambeke F, de Jongh R, Tulkens P.
Continuous versus intermittent infusion of temocillin in intensive care unit patient.
Critical care 2005 ; 9(Suppl 1) P37
4488
文献
Nezvalova-Henriksen K, Niklas Nilsson N, Tomine Østerberg C, Staven Berge V, Tho I.
Y-Site Physical Compatibility of Numeta G13E with Drugs Frequently Used at Neonatal Intensive Care.
Pharmaceutics 2020 ; 12, 677.
4524
海报
Stucki C, Sautter A-M, Bonnabry P.
Physical compatibility of the propofol emulsion with 33 drugs used in anaesthesiology.
ESCP Symposium, Geneva, Switzerland 2009
4528
文献
Lu J, Liu Q, Kupiec T, Vail H, Lunch L, Fam D, Vu N.
Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration.
Int J Pharm Compound 2021 ;25,1:52-61
4543
文献
Senarathna G, Strunk T, Petrovski M, Batty K.
Physical compatibility of pentoxifylline and intravenous medications.
Archives of Disease in Childhood 2018 ;104:292–295.
4569
文献
Lee T.M , Villareal C.L, Meyer L.M.
Y-Site Compatibility of Intravenous Levetiracetam With Commonly Used Critical Care Medications.
Hosp Pharm 2021 ; 56, 4: 282-286.
4603
文献
Vallée M, Barthélémy I, Friciu M, Pelletier E, Forest J.M, Benoit F, Leclair G.
Compatibility of Lactated Ringer’s Injection With 94 Selected Intravenous Drugs During Simulated Y-site Administration.
Hosp Pharm 2021 ; 56, 4: 228-234.
4634
文献
Loeuille G, D'Huart E, Vigneron J, Nisse YE, Beiler B, Polo C, Ayari G, Sacrez M, Demoré B, Charmillon A.
Stability studies of 16 Antibiotics for Continuous Infusion in Intensive Care Units and for Performing Outpatient Parenteral Antimicrobial Therapy.
Antibiotics 2022 ;11,4: 458
4654
海报
Sicard G, Donnette M, Martin N, Gensollen S, Pourroy B, Fanciullino R.
Compatibilité visuelle du Vyxeos® lors d'administration en Y avec une sélection de médicaments injectables.
Communication personnelle 2021
4655
文献
Holyk A, Lindner A, Lindner S, Shippert B
Physical compatibility of Normosol-R with critical care medications used in patients with COVID-19 during simulated Y-site administration.
Am J Health-Syst Pharm 2022 ;79,1:27-33
4698
文献
Ayari G, D'Huart E, Vigneron J, Demoré B.
Y-site compatibility of intravenous medications commonly used in intensive care units : laboratory tests on 75 mixtures involving nine main drugs.
Pharmaceutical Technology in Hospital Pharmacy 2022
4742
文献
Macoviciuc M, Nguyen C, Forest J-M, Leclair G.
Compatibilité physique de l’acétaminophène injectable avec 102 autres médicaments lors d’une administration en Y.
Pharmactuel 2022 ; 55, 4: 247-255.
4801
文献
Ruiz V, Yuwei Shen Y, Abouelhassan Y, Fouad A, Nicolau D, Kuti J.
Physical compatibility of sulbactam/durlobactam with select intravenous drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2024 ;51,1:
Mentions Légales